Billiontoone (NASDAQ:BLLN) Stock Falls 6.5% - What's Next?

Key Points

• Billiontoone shares fell 6.5% to about $101.94 in mid-day trading, with volume down 65% from the average session.
• Analyst sentiment remains cautiously positive: seven analysts rate the stock Buy, three Hold and one Sell, producing a “Moderate Buy” consensus and a $126.25 average price target.
• Insiders sold 216,357 shares worth approximately $24.6 million over the past 90 days, while the company reported quarterly EPS of $0.15 and revenue of $109.45 million.

Shares of Billiontoone, Inc. (NASDAQ:BLLN - Get Free Report) traded down 6.5% on Tuesday. The company traded as low as $101.61 and last traded at $101.9420. Approximately 192,399 shares traded hands during mid-day trading, a decline of 65% from the average session volume of 549,552 shares. The stock had previously closed at $109.06.

Wall Street Analyst Weigh In

BLLN has been the subject of several recent analyst reports. Guggenheim upped their target price on shares of Billiontoone from $125.00 to $128.00 and gave the company a "buy" rating in a research note on Thursday. Zacks Research raised shares of Billiontoone from a "strong sell" rating to a "hold" rating in a research report on Friday. Weiss Ratings reissued a "sell (d+)" rating on shares of Billiontoone in a report on Friday, September 18th. Wall Street Zen downgraded Billiontoone from a "buy" rating to a "hold" rating in a research note on Saturday, August 8th. Finally, BTIG Research reduced their target price on Billiontoone from $142.00 to $130.00 and set a "buy" rating on the stock in a report on Thursday, August 6th. Seven equities research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Billiontoone presently has a consensus rating of "Moderate Buy" and a consensus target price of $126.25.

Billiontoone Price Performance

The firm has a market capitalization of $4.73 billion and a price-to-earnings ratio of 143.48. The company's 50 day moving average is $106.67 and its 200 day moving average is $100.31. The company has a quick ratio of 11.31, a current ratio of 11.69 and a debt-to-equity ratio of 0.17.

Billiontoone (NASDAQ:BLLN - Get Free Report) last announced its quarterly earnings data on Wednesday, August 5th. The company reported $0.15 EPS for the quarter, meeting the consensus estimate of $0.15. The business had revenue of $109.45 million during the quarter. Billiontoone had a net margin of 8.04% and a return on equity of 9.96%. On average, equities research analysts anticipate that Billiontoone, Inc. will post 0.83 earnings per share for the current fiscal year.

Insider Transactions at Billiontoone

In other Billiontoone news, insider Thomas P. Lynch sold 35,112 shares of the business's stock in a transaction on Thursday, September 17th. The shares were sold at an average price of $110.33, for a total transaction of $3,873,906.96. Following the completion of the sale, the insider owned 700 shares in the company, valued at approximately $77,231. The trade was a 98.05% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CTO David Tsao sold 20,000 shares of the firm's stock in a transaction that occurred on Wednesday, September 9th. The shares were sold at an average price of $98.77, for a total value of $1,975,400.00. Following the completion of the transaction, the chief technology officer owned 1,000 shares in the company, valued at $98,770. This represents a 95.24% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 216,357 shares of company stock valued at $24,589,056. Corporate insiders own 50.22% of the company's stock.

Hedge Funds Weigh In On Billiontoone

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Integrated Wealth Concepts LLC purchased a new stake in Billiontoone during the 2nd quarter valued at about $29,000. MCF Advisors LLC grew its holdings in shares of Billiontoone by 330.8% in the second quarter. MCF Advisors LLC now owns 448 shares of the company's stock worth $54,000 after purchasing an additional 344 shares during the last quarter. Thrive Wealth Management LLC purchased a new position in shares of Billiontoone in the second quarter worth $240,000. Caitong International Asset Management Co. Ltd purchased a new stake in Billiontoone during the 4th quarter valued at $230,000. Finally, Jasper Ridge Partners L.P. bought a new stake in Billiontoone in the 2nd quarter worth $615,000.

Billiontoone Company Profile

BillionToOne, Inc NASDAQ: BLLN is a molecular diagnostics company that develops blood-based genetic tests designed to provide more information from small amounts of cell-free DNA. The company's platform uses proprietary molecular counting technology to improve the sensitivity and accuracy of diagnostic testing.

BillionToOne's primary business is reproductive health testing. Its UNITY portfolio is designed to support prenatal screening, including testing for chromosomal conditions and single-gene disorders, and is intended to provide physicians and expectant parents with information from a maternal blood sample.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.